Journal News

Receptor regulation clues may scratch an itch

Anna Crysler
Nov. 14, 2023

Whether you’ve been stung by an insect or suffer from allergies, most people have experienced itchy skin, which usually can be relieved with time or simple remedies. However, for certain patients with liver disease, an intense itching sensation, known as cholestatic pruritis — the medical term for itch — often does not respond to standard treatments.

This predicted complex formation between MRGPRX4 (maroon) and RAMP2 (green) was generated with AlphaFold-Multimer and interacting residues shown as surfaces were calculated by PDBePISA.
This predicted complex formation between MRGPRX4 (maroon) and RAMP2 (green) was generated with AlphaFold-Multimer and interacting residues shown as surfaces were calculated by PDBePISA.

Thomas Sakmar’s lab at the Rockefeller University uses biochemical and biophysical methods to study transmembrane signal transduction by G protein-coupled receptors. GPCRs play an important role in human physiology; they make up the largest family of membrane proteins and mediate many signaling pathways. Therefore, these receptors are frequent drug targets for a wide variety of diseases and disorders such as cancer, depression, hypertension and more.

In a recent paper in the Journal of Biological Chemistry, Sakmar and his team write about their work on the regulation of a particular GPCR through receptor activity–modifying protein 2, or RAMP2. This receptor, mas-related GPCR subtype X4, or MRGPRX4, is associated with cholestatic itch and is present in the sensory neurons of the skin.

“Our research is unique in that it illustrates a role for RAMPs in MRGPRX4 biology,” Sakmar said. “Since GPCRs represent the molecular targets of approximately one-third of current Food and Drug Administration-approved drugs, a better understanding of GPCR regulation can lead to the development of more potent and selective drugs for a large range of diseases.”

The Sakmar lab had already collaborated to create a multiplexed screening platform to better understand and explore how commonly expressed GPCRs interact with RAMPs. With this technology they identified, for the first time, MRGPRX4 interacting with RAMP2, which they further characterized using pharmacological and computational methods.

In addition to characterizing the MRGPRX4–RAMP2 complex, Sakmar’s team studied how bile acids can activate the receptor. The slowing or stopping of the flow of bile from the liver, known as cholestasis, is believed to cause intense itching in patients with cholestatic disorders. Bile acids are elevated in patients with liver disease, so, taken together with the newly discovered MRGPRX4–RAMP2 interaction, this research improves a broader understanding of the role MRGPRX4 plays in cholestatic itch.

Researchers need to understand the regulation of GPCRs to elucidate how therapies act on these receptors, Sakmar said. “Our discovery that many GPCRs, including MRGPRX4, are regulated by RAMPs might improve drug discovery paradigms, and it is possible that our work might lead to new drugs to treat cholestatic itch or minimize the chance that a drug candidate might cause itch as a side effect.”

The lab plans to take their findings to the next level by increasing the depth and breadth of their work, Sakmar said. “We plan to study the MRGPRX4–RAMP2 interaction in primary skin cells to gain a better understanding of how this protein–protein interaction affects the pharmacology of MRGPRX4 in a highly physiologically relevant environment.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anna Crysler

Anna Crysler holds a B.A. in biochemistry from Albion College and is a is a Ph.D. student in bioengineering at the University of Pennsylvania. She is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.